Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Testing the Developmental Origins Hypothesis (CHIPS-Child)

1. marts 2012 opdateret af: Laura Magee, Children's & Women's Health Centre of British Columbia

CHIPS-Child:Testing the Developmental Origins Hypothesis

INTRODUCTION: CHIPS-Child is a parallel, ancillary study to the CHIPS randomized controlled trial (RCT). CHIPS is designed to determine whether 'less tight' control [target diastolic BP (dBP) 100mmHg] or 'tight' control [target dBP 85mmHg] of non-proteinuric hypertension in pregnancy is better for the baby without increasing maternal risk.

CHIPS-Child is a follow up study at 12 m corrected post-gestational age (± 2 m) limited to non-invasive examination [anthropometry, hair cortisol, buccal swabs for epigenetic testing and a maternal questionnaire about infant feeding practices and background]. Annual contact will be maintained in years 2-5 and contact will include annual parental measurement of the child's height, weight and waist circumference.

OBJECTIVE: To directly test, for the first time in humans, whether differential blood pressure (BP) control in pregnancy has developmental programming effects, independent of birthweight. We predict that, like famine or protein malnutrition, 'tight' (vs. 'less tight') control of maternal BP will be associated with fetal under-nutrition and effects will be consistent with developmental programming.

Studieoversigt

Status

Ukendt

Betingelser

Detaljeret beskrivelse

INTRODUCTION: Growing evidence shows that reduced fetal growth rate is associated with adult cardiovascular risk markers (e.g., obesity) and disease, and evidence worldwide indicates that this relationship is independent of birthweight. The leading theory describes 'developmental programming' in utero leading to permanent alteration of the fetal genome. While those changes are adaptive in utero, they may be maladaptive postnatally.

OBJECTIVE: To directly test, for the first time in humans, whether differential blood pressure (BP) control in pregnancy has developmental programming effects, independent of birthweight. We predict that, like famine or protein malnutrition, 'tight' (vs. 'less tight') control of maternal BP will be associated with fetal under-nutrition and effects will be consistent with developmental programming.

METHODS: CHIPS-Child is a parallel, ancillary study to the CHIPS randomized controlled trial (RCT). CHIPS is designed to determine whether 'less tight' control [target diastolic BP (dBP) 100mmHg] or 'tight' control [target dBP 85mmHg] of non-proteinuric hypertension in pregnancy is better for the baby without increasing maternal risk.

CHIPS-Child is a follow up study at 12 m corrected post-gestational age (± 2 m) limited to non-invasive examination [anthropometry, hair cortisol, buccal swabs for epigenetic testing and a maternal questionnaire about infant feeding practices and background]. Annual contact will be maintained in years 2-5 and contact will include annual parental measurement of the child's height, weight and waist circumference.

Sample size:. CHIPS will recruit 1028 women. We estimate that 80% of CHIPS centres will participate in CHIPS-Child, approximately 97% of babies will survive, and 90% of children will be followed to 12 m resulting in a sample size of 626. Power will be >80% to detect a between-group difference of ≥0.25 in 'change in z-score for weight' between birth and 12 m (2-sided alpha=0.05, SD 1).

Undersøgelsestype

Observationel

Tilmelding (Forventet)

626

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

      • Ipswich, Australien
        • Rekruttering
        • Ipswich Hospital
      • Subiaco, Australien
        • Rekruttering
        • King Edward Memorial Hospital
    • Alberta
      • Edmonton, Alberta, Canada
        • Rekruttering
        • Royal Alexandra Hospital
    • British Columbia
      • Surrey, British Columbia, Canada
        • Rekruttering
        • Surrey Memorial Hospital: Jim Pttison Outpatient Care & Surgery Centre
      • Vancouver, British Columbia, Canada, V6H 3N1
        • Rekruttering
        • BC Children & Women's Health Centre
        • Ledende efterforsker:
          • Laura A Magee, MD FRCPC MSc
    • Nova Scotia
      • Halifax, Nova Scotia, Canada
        • Rekruttering
        • IWK Health Centre
    • Ontario
      • London, Ontario, Canada
        • Rekruttering
        • London Health Sciences Centre
      • Sherbrooke, Ontario, Canada
        • Rekruttering
        • CHUS Fleurimont
      • Toronto, Ontario, Canada
        • Rekruttering
        • Sunnybrook Health Sciences Centre
    • Quebec
      • Montreal, Quebec, Canada
        • Rekruttering
        • Hopital Sainte-Justine
    • Saskatchewan
      • Saskatoon, Saskatchewan, Canada
        • Rekruttering
        • Royal University Hospital
      • Osorno, Chile
        • Rekruttering
        • Hospital Base Osorno
      • Puente Alto, Chile
        • Rekruttering
        • Hospital Dr Sotero del Rio
      • Birmingham, Det Forenede Kongerige
        • Rekruttering
        • Birmingham Women's Hospital
      • Bradford, Det Forenede Kongerige
        • Rekruttering
        • Bradford Royal Infirmary
      • Lancaster, Det Forenede Kongerige
        • Rekruttering
        • Royal Lancaster Infirmary
      • Newcastle Upon Tyne, Det Forenede Kongerige
        • Rekruttering
        • Royal Victoria Infirmary
      • Nottingham, Det Forenede Kongerige
        • Rekruttering
        • Nottingham City Hospital
      • Ormskirk, Det Forenede Kongerige
        • Rekruttering
        • Southport & Ormskirk Hospital
      • Plymouth, Det Forenede Kongerige
        • Rekruttering
        • Derriford Hospital
      • Sunderland, Det Forenede Kongerige
        • Rekruttering
        • City Hospitals Sunderland NHS Foundation Trust
      • Swansea, Det Forenede Kongerige
        • Rekruttering
        • Singleton Hospital
      • Wolverhampton, Det Forenede Kongerige
        • Rekruttering
        • New Cross Hospital
      • York, Det Forenede Kongerige
        • Rekruttering
        • York District Hospital
      • Tartu, Estland
        • Rekruttering
        • Tartu University Hospital - Women's Clinic
    • Connecticut
      • New Haven, Connecticut, Forenede Stater, 06510
        • Rekruttering
        • Yale-New Haven Hospital
    • Kentucky
      • Louisville, Kentucky, Forenede Stater, 40202
        • Rekruttering
        • Norton Hospital Downtown & Suburban
    • New Jersey
      • Camden, New Jersey, Forenede Stater, 08103
        • Rekruttering
        • Copper University Hospital
    • Oregon
      • Portland, Oregon, Forenede Stater, 97239
        • Rekruttering
        • Oregon Health & Science University
      • Amsterdam, Holland
        • Rekruttering
        • OLVG
      • Amsterdam, Holland
        • Rekruttering
        • Academic Medical Center
      • Amsterdam, Holland
        • Rekruttering
        • VU Medical Center
      • Groningen, Holland
        • Rekruttering
        • UMCG
      • Hilversum, Holland
        • Rekruttering
        • Tergooiziekenhuizen
      • Maastricht, Holland
        • Rekruttering
        • MUMC Maastricht
      • Nieuwegein, Holland
        • Rekruttering
        • St Antonius Ziekenhuis
      • Utrecht, Holland
        • Rekruttering
        • UMCU
      • Utrecht, Holland
        • Rekruttering
        • Diakonessen Ziekenhuis
      • Veldhoven, Holland
        • Rekruttering
        • Maxima Medical Centre
      • Zwolle, Holland
        • Rekruttering
        • Isala Klinieken Zwolle
      • Christchurch, New Zealand
        • Rekruttering
        • Christchurch Women's Hospital

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Barn
  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

Only women participating in the CHIPS RCT and their children born after recruitment are eligible to participate in CHIPS-Child.

Beskrivelse

Inclusion Criteria:

  • All women participating in CHIPS and their children born after recruitment.

Exclusion Criteria:

  • Women who have experienced the loss of their pregnancy or child after recruitment into CHIPS.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Kohorter og interventioner

Gruppe / kohorte
Tight
Children born to women in the CHIPS RCT randomized to "Tight" blood pressure control [target diastolic BP 85mmHg]
Less Tight
Children born to women in the CHIPS RCT randomized to "Less Tight" [target diastolic BP 100mmHg].

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
difference in 'change in z score for weight' at 12 m(+/- 2m)
Tidsramme: birth to 12m (+/-2m) of age, 24m, 36m, 48m, 60m
Between-group difference in early postnatal weight gain ('change in z score for weight') between birth and 12 m (p<0.05), 24m, 36m, 48m & 60m.
birth to 12m (+/-2m) of age, 24m, 36m, 48m, 60m

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
hypothalamic pituitary adrenal axis function
Tidsramme: average of 12m (+/-2m) of age
Hair collected at 12m (+/-2m) of age will be analysed for hypothalamic pituitary adrenal axis function (hair cortisol for overall cortisol production).
average of 12m (+/-2m) of age
differences in DNA methylation
Tidsramme: average of 12 m (+/- 2m) of age
Buccal swab samples collected at 12m (+/-2m) of age will be assessed for between-groups differences in DNA methylation, using targeted (genes associated with growth, obesity, cardiovascular disease, and/or a developmental programming effect) and global (genome-wide microarray) methods.
average of 12 m (+/- 2m) of age

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Laura A Magee, MD, BC Children & Women's Health Centre

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Generelle publikationer

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. januar 2012

Primær færdiggørelse (Forventet)

1. januar 2019

Studieafslutning (Forventet)

1. januar 2019

Datoer for studieregistrering

Først indsendt

24. februar 2012

Først indsendt, der opfyldte QC-kriterier

1. marts 2012

Først opslået (Skøn)

6. marts 2012

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

6. marts 2012

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

1. marts 2012

Sidst verificeret

1. marts 2012

Mere information

Begreber relateret til denne undersøgelse

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner